Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Nature Reviews. Clinical Oncology
|
March 2, 2016
Evolving molecularly targeted therapies for advanced-stage thyroid cancers
Keith C Bible, Mabel Ryder
Expert Opinion on Investigational Drugs
|
September 14, 2011
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
Pamela Jo Harris, Keith C Bible
Endocrine-Related Cancer
|
May 18, 2016
New drugs for medullary thyroid cancer: new promises?
Christine Spitzweg, John C Morris, Keith C Bible
Antioxidants & Redox Signaling
|
February 23, 2010
Annatto constituent cis-bixin has selective antimyeloma effects mediated by oxidative stress and associated with inhibition of thioredoxin and thioredoxin reductase
Jennifer D Tibodeau, Crescent R Isham, Keith C Bible
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Systemic therapeutic approaches to advanced thyroid cancers
Michael E Menefee, Robert C Smallridge, Keith C Bible
Journal of Bone Oncology
|
March 11, 2020
Bone metastases in thyroid cancer
Nicole M Iñiguez-Ariza, Keith C Bible, Bart L Clarke
The Lancet. Diabetes & Endocrinology
|
June 6, 2014
Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets
Christine Spitzweg, Keith C Bible, Lorenz C Hofbauer, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy
Yean Kit Lee, Crescent R Isham, Scott H Kaufman, et al.
Endocrinology and Metabolism Clinics of North America
|
February 6, 2019
Diagnosis and Management of Anaplastic Thyroid Cancer
Ashish V Chintakuntlawar, Robert L Foote, Jan L Kasperbauer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 5, 2017
Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer
Nicole M Iñiguez-Ariza, Mabel M Ryder, Crystal R Hilger, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Nature Reviews. Clinical Oncology
|
March 2, 2016
Evolving molecularly targeted therapies for advanced-stage thyroid cancers
Keith C Bible, Mabel Ryder
Expert Opinion on Investigational Drugs
|
September 14, 2011
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
Pamela Jo Harris, Keith C Bible
Endocrine-Related Cancer
|
May 18, 2016
New drugs for medullary thyroid cancer: new promises?
Christine Spitzweg, John C Morris, Keith C Bible
Antioxidants & Redox Signaling
|
February 23, 2010
Annatto constituent cis-bixin has selective antimyeloma effects mediated by oxidative stress and associated with inhibition of thioredoxin and thioredoxin reductase
Jennifer D Tibodeau, Crescent R Isham, Keith C Bible
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Systemic therapeutic approaches to advanced thyroid cancers
Michael E Menefee, Robert C Smallridge, Keith C Bible
Journal of Bone Oncology
|
March 11, 2020
Bone metastases in thyroid cancer
Nicole M Iñiguez-Ariza, Keith C Bible, Bart L Clarke
The Lancet. Diabetes & Endocrinology
|
June 6, 2014
Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets
Christine Spitzweg, Keith C Bible, Lorenz C Hofbauer, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy
Yean Kit Lee, Crescent R Isham, Scott H Kaufman, et al.
Endocrinology and Metabolism Clinics of North America
|
February 6, 2019
Diagnosis and Management of Anaplastic Thyroid Cancer
Ashish V Chintakuntlawar, Robert L Foote, Jan L Kasperbauer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 5, 2017
Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer
Nicole M Iñiguez-Ariza, Mabel M Ryder, Crystal R Hilger, et al.
Page
of 6